Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Reference is made to the stock exchange notice on 6 October 2020. HBC has now received approval from Health Canada for Qualified Health Claims (QHCs) for its Salmon Protein Hydrolysate (ProGo® and...
-
Reference is made to the stock exchange notice from Hofseth BioCare ASA dated 16 October 2020 regarding the private placement of NOK 200m (the "Private Placement"). As a consequence of the Private...
-
Reference is made to the announcement by Hofseth BioCare ASA on 16 October 2020 concerning the completion of a private placement with total gross proceeds of approximately NOK 200 million and a...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION...
-
Hofseth BioCare (HBC) submitted a notification to the Food and Drug Administration (FDA) for the use of six structure function claims for ProGo®’s Bioactive Peptides™. The FDA did not oppose the use...
-
As reported earlier in the quarterly reports in 2019 and 2020, HBC have had feedback that the application to Health Canada for Qualified Health Claims for its Salmon Protein Hydrolysate (ProGo®) is...
-
Reference is made to the stock exchange notice on 26 May 2020 and 30 June 2020. Hofseth BioCare ASA (“HBC”) announces that the first part of its accelerated phase 2 trial of CARDIO™ soft gels for the...
-
Reference is made to the stock exchange notice dated 28 August 2020 regarding issuance of 1,135,120 new shares to James Berger, Head of Investor Relations & Strategy, following exercise of share...
-
An in-vitro study published in the journal Functional Foods in Health and Disease (2020; 10(8):357-367) shows the therapeutic potential of HBC’s OmeGo® salmon oil for the treatment of certain types of...